Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Metabolyz vs QuickMD

Metabolyz
Graded #339

Lower grade

vs+5.300000000000004
QuickMD
Graded #238

Higher grade

The verdict

QuickMD takes it — 64.9/100 to 59.6/100.

QuickMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. QuickMD is a high-volume telemedicine platform (over 1 million visits) offering same-day online weight-management care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationQuickMD +36
40
76
Clinical oversightQuickMD +5
81
86
Labs & monitoringMetabolyz +11
63
52
FulfillmentMetabolyz +15
86
71
Contract termsQuickMD +6
55
61
Metabolyz · left barQuickMD · right bar

The numbers

MetricMetabolyzQuickMD
WeighScore59.6/10064.9/100
GradeCC
Scorecard rank#339#238
SemaglutideNot disclosed$279/mo (compounded)
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Metabolyz

Graded #339 · C

Strengths

  • Three GLP-1 programs: standard semaglutide, dual-agonist tirzepatide, and a microdose protocol for near-goal or dose-sensitive patients
  • Nutrition, movement, and lifestyle coaching included in all programs at no extra charge
  • Medication compounded in licensed 503A/503B US pharmacies with temperature-controlled, unmarked direct-to-door delivery
  • Licensed provider supervision with direct messaging access and structured check-ins throughout
  • Telehealth across all 50 states; BMI 27+ eligibility (25+ with weight-related condition)

Where it loses points

  • Pricing is fully gated — not disclosed until after consultation, preventing upfront cost comparison
  • Compounded GLP-1 only — no brand-name options (Wegovy, Zepbound) available
  • No LegitScript certification or named medical leadership found on public-facing pages
  • Labs not mentioned as included — unclear whether baseline or follow-up bloodwork is offered
  • Newer brand with no external reviews, published outcomes data, or notable accreditations
QuickMD

Graded #238 · C

Strengths

  • Compounded semaglutide around $279/mo plus brand-name GLP-1 options
  • Same-day, 365-day-a-year online visits
  • Large established platform with over 1 million completed visits
  • Transparent cash-pay pricing with reimbursement summaries
  • Can prescribe Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus

Where it loses points

  • Does not accept insurance
  • Available in 45+ states, not all 50
  • Medication cost varies by pharmacy, not fully bundled
  • No named board-certified physicians listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard